ω-3脂肪酸对晚期非小细胞肺癌患者C反应蛋白和白细胞介素-6的影响。
Effect of omega 3 fatty acids on C-reactive protein and interleukin-6 in patients with advanced nonsmall cell lung cancer.
作者信息
Lu Yan, Chen Ren-Gang, Wei San-Zou, Hu Han-Guo, Sun Fei, Yu Chun-Hui
机构信息
Department of Clinical Laboratory, The First People's Hospital of Xiaochang, Xiaochang Department of Clinical Laboratory, Xiaogan Central Hospital, Xiaogan County, Hubei, China.
出版信息
Medicine (Baltimore). 2018 Sep;97(37):e11971. doi: 10.1097/MD.0000000000011971.
Abstract
This study investigated the anti-inflammatory effects of omega 3 fatty acids (O3FAs) for patients with advanced nonsmall cell lung cancer (ANSCLC).A total of 137 patients with ANSCLC were included in this study. Of those, 77 patients underwent O3FA and were assigned to a treatment group, while 60 patients did not receive it, and were assigned to a control group. C-reactive protein (CRP), and interleukin (IL)-6 levels, as well as the levels of tumor necrosis factor-alpha (TNFα) and prostaglandin E2 (PGE2) were checked. In addition, nutritional status and quality of life were also evaluated. All patients in the treatment group received a total of 6 weeks treatment.After 6 weeks treatment, patients in the treatment group exerted better outcomes in CRP and IL-6, although no significant differences were found in nutritional status, as well as the quality, compared with patients in the control group.The results of this retrospective study found that O3FA may change levels of CRP and IL-6, except the nutritional status and quality of life.
摘要
本研究调查了ω-3脂肪酸（O3FAs）对晚期非小细胞肺癌（ANSCLC）患者的抗炎作用。本研究共纳入137例晚期非小细胞肺癌患者。其中，77例患者接受了O3FA治疗并被分配到治疗组，而60例患者未接受该治疗，被分配到对照组。检测了C反应蛋白（CRP）、白细胞介素（IL）-6水平，以及肿瘤坏死因子-α（TNFα）和前列腺素E2（PGE2）水平。此外，还评估了营养状况和生活质量。治疗组所有患者共接受6周治疗。治疗6周后，治疗组患者在CRP和IL-6方面取得了更好的结果，尽管与对照组患者相比，在营养状况和生活质量方面未发现显著差异。这项回顾性研究的结果发现，O3FA可能会改变CRP和IL-6水平，但不会影响营养状况和生活质量。
相似文献
1
Effect of omega 3 fatty acids on C-reactive protein and interleukin-6 in patients with advanced nonsmall cell lung cancer.ω-3脂肪酸对晚期非小细胞肺癌患者C反应蛋白和白细胞介素-6的影响。
Medicine (Baltimore). 2018 Sep;97(37):e11971. doi: 10.1097/MD.0000000000011971.
2
Randomized Study of the Effect of Vitamin D and Omega-3 Fatty Acids Cosupplementation as Adjuvant Chemotherapy on Inflammation and Nutritional Status in Colorectal Cancer Patients.维生素D与ω-3脂肪酸联合补充作为辅助化疗对结直肠癌患者炎症和营养状况影响的随机研究
J Diet Suppl. 2020;17(4):384-400. doi: 10.1080/19390211.2019.1600096. Epub 2019 May 20.
3
4
Randomized Study Design to Test Effects of Vitamin D and Omega-3 Fatty Acid Supplementation as Adjuvant Therapy in Colorectal Cancer Patients.随机研究设计，以测试维生素 D 和欧米伽-3 脂肪酸补充剂作为结直肠癌患者辅助治疗的效果。
Methods Mol Biol. 2020;2138:337-350. doi: 10.1007/978-1-0716-0471-7_24.
5
Effect of intradialytic intravenous administration of omega-3 fatty acids on nutritional status and inflammatory response in hemodialysis patients: a pilot study.ω-3 脂肪酸透内静脉给药对血液透析患者营养状况和炎症反应的影响：一项初步研究。
J Ren Nutr. 2009 Nov;19(6):487-93. doi: 10.1053/j.jrn.2009.05.007. Epub 2009 Jul 17.
6
Can Inflammatory and Nutritional Serum Markers Predict Chemotherapy Outcomes and Survival in Advanced Stage Nonsmall Cell Lung Cancer Patients?炎症和营养血清标志物能否预测晚期非小细胞肺癌患者的化疗结局和生存？
Biomed Res Int. 2019 Feb 28;2019:1648072. doi: 10.1155/2019/1648072. eCollection 2019.
7
Omega-3 fatty acids, inflammatory status and biochemical markers of patients with systemic lupus erythematosus: a pilot study.欧米伽-3脂肪酸、系统性红斑狼疮患者的炎症状态及生化指标：一项初步研究。
Rev Bras Reumatol Engl Ed. 2017 Nov-Dec;57(6):526-534. doi: 10.1016/j.rbre.2016.09.014. Epub 2016 Oct 22.
8
Effects of oral supplementation with omega-3 fatty acids on nutritional state and inflammatory markers in maintenance hemodialysis patients.口服补充ω-3脂肪酸对维持性血液透析患者营养状况和炎症标志物的影响。
J Ren Nutr. 2014 May;24(3):177-85. doi: 10.1053/j.jrn.2014.01.014. Epub 2014 Mar 7.
9
Effect of marine-derived n-3 polyunsaturated fatty acids on C-reactive protein, interleukin 6 and tumor necrosis factor α: a meta-analysis.海洋来源的n-3多不饱和脂肪酸对C反应蛋白、白细胞介素6和肿瘤坏死因子α的影响：一项荟萃分析。
PLoS One. 2014 Feb 5;9(2):e88103. doi: 10.1371/journal.pone.0088103. eCollection 2014.
10
Dietary omega-3 polyunsaturated fatty acids plus vitamin E restore immunodeficiency and prolong survival for severely ill patients with generalized malignancy: a randomized control trial.膳食ω-3多不饱和脂肪酸加维生素E可恢复重症全身性恶性肿瘤患者的免疫缺陷并延长其生存期：一项随机对照试验。
Cancer. 1998 Jan 15;82(2):395-402. doi: 10.1002/(sici)1097-0142(19980115)82:2<403::aid-cncr21>3.0.co;2-1.
引用本文的文献
1
Omega-6/Omega-3 Ratio as a Protective Factor in Lung Cancer: A Mendelian Randomization Study on Polyunsaturated Fatty Acids and Lung Adenocarcinoma Risk.欧米伽-6/欧米伽-3 比例作为肺癌的保护因素：一项关于多不饱和脂肪酸与肺腺癌风险的孟德尔随机化研究
J Cancer. 2025 Jun 12;16(8):2649-2662. doi: 10.7150/jca.112416. eCollection 2025.
2
Perspective: Implications of Docosahexaenoic Acid and Eicosapentaenoic Acid Supplementation on the Immune System during Cancer Chemotherapy: Perspectives from Current Clinical Evidence.观点：二十二碳六烯酸和二十碳五烯酸补充剂对癌症化疗期间免疫系统的影响：基于当前临床证据的观点
Adv Nutr. 2025 Jun 14;16(8):100464. doi: 10.1016/j.advnut.2025.100464.
3
Roles and therapeutic opportunities of ω-3 long-chain polyunsaturated fatty acids in lung cancer.ω-3长链多不饱和脂肪酸在肺癌中的作用及治疗机会
iScience. 2024 Dec 14;28(1):111601. doi: 10.1016/j.isci.2024.111601. eCollection 2025 Jan 17.
4
Effects of omega-3 fatty acid supplementation on nutritional status and inflammatory response in patients with stage II-III NSCLC undergoing postoperative chemotherapy: a double-blind randomized controlled trial.ω-3脂肪酸补充剂对II-III期非小细胞肺癌术后化疗患者营养状况和炎症反应的影响：一项双盲随机对照试验
Front Nutr. 2023 Oct 26;10:1266584. doi: 10.3389/fnut.2023.1266584. eCollection 2023.
5
Efficacy of -3 Polyunsaturated Fatty Acids in Patients with Lung Cancer Undergoing Radiotherapy and Chemotherapy: A Meta-Analysis.-3 多不饱和脂肪酸在放化疗肺癌患者中的疗效：一项荟萃分析。
Int J Clin Pract. 2022 Jul 8;2022:6564466. doi: 10.1155/2022/6564466. eCollection 2022.
6
Mendelian Randomization Study of Causal Relationship between Omega-3 Fatty Acids and Risk of Lung Cancer.基于孟德尔随机化研究的ω-3 脂肪酸与肺癌风险的因果关系。
Biomed Res Int. 2022 May 31;2022:2786567. doi: 10.1155/2022/2786567. eCollection 2022.
7
Associations between omega-3 polyunsaturated fatty acids supplementation and surgical prognosis in patients with gastrointestinal cancer: A systematic review and meta-analysis.ω-3多不饱和脂肪酸补充剂与胃肠道癌患者手术预后的关联：一项系统评价和荟萃分析。
Food Chem (Oxf). 2022 Mar 12;4:100099. doi: 10.1016/j.fochms.2022.100099. eCollection 2022 Jul 30.
8
Total Lipids, Fatty Acid Composition, Total Cholesterol and Lipid-Soluble Antioxidant Vitamins in the Muscle of Water Buffalo () from Different Production Systems of the Brazilian Eastern Amazon.巴西东部亚马逊地区不同生产系统的水牛（）肌肉中的总脂质、脂肪酸组成、总胆固醇和脂溶性抗氧化维生素
Animals (Basel). 2022 Feb 27;12(5):595. doi: 10.3390/ani12050595.
9
Omega-3 Fatty Acids Supplementation Improve Nutritional Status and Inflammatory Response in Patients With Lung Cancer: A Randomized Clinical Trial.补充ω-3脂肪酸改善肺癌患者的营养状况和炎症反应：一项随机临床试验。
Front Nutr. 2021 Jul 30;8:686752. doi: 10.3389/fnut.2021.686752. eCollection 2021.
10
N-3 Long-Chain Polyunsaturated Fatty Acids, Eicosapentaenoic and Docosahexaenoic Acid, and the Role of Supplementation during Cancer Treatment: A Scoping Review of Current Clinical Evidence.N-3长链多不饱和脂肪酸、二十碳五烯酸和二十二碳六烯酸以及癌症治疗期间补充剂的作用：当前临床证据的范围综述
Cancers (Basel). 2021 Mar 10;13(6):1206. doi: 10.3390/cancers13061206.
本文引用的文献
1
Primary malignant myopericytoma with cancer cachexia: Report of the first case and review of literature.伴有癌性恶病质的原发性恶性肌周细胞瘤：首例病例报告及文献复习
Medicine (Baltimore). 2017 Dec;96(49):e9064. doi: 10.1097/MD.0000000000009064.
2
Tonsillar metastasis of nonsmall cell lung cancer with G719S mutation in exon 18: A case report.18号外显子G719S突变的非小细胞肺癌扁桃体转移：一例报告
Medicine (Baltimore). 2017 Dec;96(49):e9003. doi: 10.1097/MD.0000000000009003.
3
The prognostic value of the serum neuron specific enolase and lactate dehydrogenase in small cell lung cancer patients receiving first-line platinum-based chemotherapy.血清神经元特异性烯醇化酶和乳酸脱氢酶在接受一线铂类化疗的小细胞肺癌患者中的预后价值。
Medicine (Baltimore). 2017 Nov;96(46):e8258. doi: 10.1097/MD.0000000000008258.
4
Circulating 25-hydroxyvitamin D and lung cancer risk and survival: A dose-response meta-analysis of prospective cohort studies.循环25-羟维生素D与肺癌风险及生存：前瞻性队列研究的剂量反应荟萃分析
Medicine (Baltimore). 2017 Nov;96(45):e8613. doi: 10.1097/MD.0000000000008613.
5
Risk of rash associated with vandetanib treatment in non-small-cell lung cancer patients: A meta-analysis of 9 randomized controlled trials.凡德他尼治疗非小细胞肺癌患者时出现皮疹的风险：9项随机对照试验的荟萃分析
Medicine (Baltimore). 2017 Oct;96(43):e8345. doi: 10.1097/MD.0000000000008345.
6
A multidisciplinary rehabilitation programme for cancer cachexia improves quality of life.一项针对癌症恶病质的多学科康复计划可改善生活质量。
BMJ Support Palliat Care. 2017 Dec;7(4):441-449. doi: 10.1136/bmjspcare-2017-001382. Epub 2017 Aug 28.
7
Genetic characterization drives personalized therapy for early-stage non-small-cell lung cancer (NSCLC) patients and survivors with metachronous second primary tumor (MST): A case report.基因特征分析推动早期非小细胞肺癌（NSCLC）患者及异时性第二原发性肿瘤（MST）幸存者的个性化治疗：一例报告。
Medicine (Baltimore). 2017 Mar;96(10):e6221. doi: 10.1097/MD.0000000000006221.
8
Concomitant etoposide and cisplatin provided improved survival compared with docetaxel and cisplatin in patients with locally advanced non-small cell lung cancer treated with chemoradiotherapy.对于接受放化疗的局部晚期非小细胞肺癌患者，与多西他赛和顺铂联合治疗相比，依托泊苷和顺铂联合治疗可提高生存率。
Medicine (Baltimore). 2016 Jul;95(30):e4280. doi: 10.1097/MD.0000000000004280.
9
Treatment-Related Death during Concurrent Chemoradiotherapy for Locally Advanced Non-Small Cell Lung Cancer: A Meta-Analysis of Randomized Studies.局部晚期非小细胞肺癌同步放化疗期间与治疗相关的死亡：一项随机研究的荟萃分析
PLoS One. 2016 Jun 14;11(6):e0157455. doi: 10.1371/journal.pone.0157455. eCollection 2016.
10
Pulmonary Toxicities of Gefitinib in Patients With Advanced Non-Small-Cell Lung Cancer: A Meta-Analysis of Randomized Controlled Trials.吉非替尼对晚期非小细胞肺癌患者的肺部毒性：随机对照试验的荟萃分析
Medicine (Baltimore). 2016 Mar;95(9):e3008. doi: 10.1097/MD.0000000000003008.
Zotero 插件